Natac reports a turnover of €32.52 million as of mid-October
The company revises its full-year forecasts and expects to close the year with revenues of €52 million and normalized EBITDA of €24.5 million.
Natac Natural Ingredients, has reported its preliminary results as of 15 October 2026, with consolidated turnover of €32.52 million and normalised EBITDA of €13.15 million. These figures represent increases of 123% and 686%, respectively, compared with the first half of the financial year, which closed with revenue of €14.58 million.
By year-end, Natac has €11.55 million worth of outstanding orders yet to be fulfilled, meaning that 85% of its annual sales budget is already covered by its order book, giving the company a high level of confidence in achieving its initially projected annual target.
For the full year 2026, the company has revised its forecasts and now expects turnover of approximately €52 million and normalised EBITDA of around €24.5 million.
This adjustment reflects a strategy focused on prioritising higher-margin products, as well as the launch in 2027 of certain API ingredients currently under negotiation.
As Antonio Delgado, Natac's CEO, explains: “We are prioritising profitability over volume, focusing our efforts on the products and markets that generate the greatest value for the company. This strategy may result in more moderate growth in the short term, but it allows us to move towards a stronger, more efficient and more profitable business model.”